Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders Proceedings of a Workshop (2017) / Chapter Skim
Currently Skimming:
Appendix C: Registered Attendees
Appendix C: Registered Attendees
Pages 77-82
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 77... ...
Lundbeck A/S Association of American Universities Megan Anderson Brooks Cavarocchi Ruscio Dennis Linda Brady Associates, LLC National Institute of Mental Health Irina Antonijevic Sanofi Genzyme Katja Brose Neuron, Cell Press 77
|
From page 78... ...
Rosa Canet-Aviles Rebecca Dresser Foundation for the National Washington University Law Institutes of Health School Franklin Carrero-Martinez Billy Dunn National Science Foundation Food and Drug Administration Elzbieta Chalecka-Franaszek Food and Drug Emmeline Edwards Administration National Center for Complementary and Karen Chandross Integrative Health Sanofi Jan Egebjerg Jason Chen H Lundbeck A/S Verge Genomics Nita Farahany Tess Chidlow Duke University School of Private Practice Law Jonathan Cohen Mehdi Farokhnia Princeton University National Institutes of Health Doug Cole Guoping Feng Flagship Ventures Massachusetts Institute of Technology Robert Conley Eli Lilly and Company
|
From page 79... ...
Stephen Huhn StemCells, Inc. Chris Gorini Food and Drug Steven Hyman Administration Stanley Center for Psychiatric Research Meg Grabb National Institute of Mental Debbie Indyk Health Icahn School of Medicine at Mount Sinai Henry Greely Stanford University Tom Jacobs The University of Texas Magali Haas System Cohen Veterans Bioscience Frances Jensen Jeri Hallberg Harmon Griffin Perelman School of Medicine Tamez at the University of Vantage College Pennsylvania Dean Hartley Alzheimer's Association
|
From page 80... ...
Food and Drug Administration David Michelson Merck & Co., Inc. John Krystal Yale School of Medicine Meghan Mott National Institute of Pascal Laeng Neurological Disorders and National Institute of Stroke Neurological Disorders and Stroke
|
From page 81... ...
Nina Espinosa National Institute on Drug University of Puerto Rico, Abuse Medical Sciences Campus Arippa Ravindran James Olds Food and Drug National Science Foundation Administration Alex Ommaya John Reppas Association of American Neurotechnology Industry Medical Colleges Organization Mary Pelleymounter Lee Rubin National Institute of Harvard University Neurological Disorders and Stroke Alexander Runko Office of Research Integrity, Niels Plath Department of Health and H Lundbeck A/S Human Services Sridevi Polavaram Erik Runko George Mason University National Science Foundation Linda Porter John Michael Sauer National Institute of Critical Path Institute Neurological Disorders and Stroke Irina Sazonova National Institute on Drug William Potter Abuse National Institute of Mental Health Eugenia Schenecker George Washington University
|
From page 82... ...
National Institute of Neurological Disorders and David Shurtleff Stroke National Center for Complementary and Doug Williamson Integrative Health Lundbeck Paul Sieving Ling Wong National Eye Institute National Institute of Neurological Disorders and Kurt Spindler Stroke Neurocurious Winifred Wu Michael Steinmetz Strategic Regulatory Partners, National Eye Institute LLC Robert Temple Suzanne Yang Food and Drug Uniformed Services Administration University of the Health Sciences William Thies Alzheimer's Association Robert Zalutsky National Institute of Wendy Toler Neurological Disorders and Consultant Stroke Jon VanLeeuwen Alice Zhang University of California, San Francisco Jason Zhang WAVE Life Sciences, Ltd. Meredith Wadman Science Magazine Stevin Zorn MindImmune Therapeutics, Inc.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.